Modulation of tryptophan catabolism by regulatory T cells

Nature Immunology

Volumn 4, Issue 12, 2003, Pages 1206-1212

  Fallarino, Francesca ^a   Grohmann, Ursula ^a   Hwang, Kwang Woo ^b   Orabona, Ciriana ^a   Vacca, Carmine ^a   Bianchi, Roberta ^a   Belladonna, Maria Laura ^a   Fioretti, Maria Cristina ^a   Alegre, Maria Luisa ^b   Puccetti, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; CD3 ANTIGEN; CD4 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; TRYPTOPHAN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; ENZYME ACTIVATION; HUMANS; IMMUNE TOLERANCE; JURKAT CELLS; LIPOPOLYSACCHARIDES; MICE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS; TRYPTOPHAN; TRYPTOPHAN OXYGENASE;

EID: 0346119234     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1003     Document Type: Article

References (44)

1. Bluestone, J.A. & Abbas, A.K. Natural versus adaptive regulatory T cells. Nat. Rev Immunol. 3, 253-257 (2003).
2. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18-32 (2001).
3. + regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
4. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389-400 (2002).
5. Shortman, K. & Heath, W.R. Immunity or tolerance? That is the question for dendritic cells. Nat. Immunol. 2, 988-989 (2001).
6. Steinman, R.M. & Nussenzweig, M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99, 351-358 (2002).
7. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310 (2000).
8. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
9. Alegre, M.L., Frauwirth, K.A. & Thompson, C.B. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 1, 220-228 (2001).
10. Thompson, C.B. & Allison, J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity 7, 445-450 (1997).
11. Oosterwegel, M.A., Greenwald, R.J., Mandelbrot, D.A., Lorsbach, R.B. & Sharpe, A.H. CTLA-4 and T cell activation. Curr. Opin. Immunol. 11, 294-300 (1999).
12. Salomon, B. & Bluestone, J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19, 225-252 (2001).
13. Sansom, D.M., Manzotti, C.N. & Zheng, Y. What's the difference between CD80 and CD86? Trends Immunol. 24, 313-318 (2003).
14. Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3, 1097-1101 (2002).
15. Finger, E.B. & Bluestone, J.A. When ligand becomes receptor - tolerance via B7 signaling on DCs. Nat. Immunol. 3, 1056-1057 (2002).
16. Munn, D.H. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191-1193 (1998).
17. Grohmann, U. et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J. Exp. Med. 198, 153-160 (2003).
18. Grohmann, U., Fallarino, F. & Puccetti, P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24, 242-248 (2003).
19. Mellor, A.L. & Munn, D.H. Tryptophan catabolism and regulation of adaptive immunity. J. Immunol. 170, 5809-5813 (2003).
20. Chuang, E. et al. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159, 144-151 (1997).
21. + immunoregulatory cells. J. Immunol. 167, 1137-1140 (2001).
22. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323 (2002).
23. Caramalho, I. et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197, 403-411 (2003).
24. + T cells activated in the presence of IFN-α 2b express functional indoleamine 2,3-dioxygenase. J. Interferon Cytokine Res. 21, 431-437 (2001).
25. Munn, D.H. et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867-1870 (2002).
26. + T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 96, 9311-9316 (1999).
27. Amrani, A. et al. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406, 739-742 (2000).
28. Grohmann, U. et al. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells. J. Immunol. 166, 277-283 (2001).
29. + dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol. 167, 708-714 (2001).
30. Grohmann, U. et al. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J. Immunol. 171, 2581-2587 (2003).
31. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
32. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183-190 (2000).
33. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30, 1538-1543 (2000).
34. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
35. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193, 1295-1302 (2001).
36. + regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507 (2002).
37. R cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111-119 (2003).
38. Bach, J.F & Chatenoud, L. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19, 131-161 (2001).
39. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194, 629-644 (2001).
40. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080-1086 (2002).
41. + subset. J. Immunol. 165, 1357-1363 (2000).
42. Grohmann, U. & Puccetti, P. CTLA-4, T helper lymphocytes and dendritic cells: an internal perspective of T-cell homeostasis. Trends Mol. Med. 9, 133-135 (2003).
43. + dendritic cells. J. Immunol. 169, 1182-1188 (2002).
44. + dendritic cells. Int. Immunol. 14, 65-68 (2002).